Burcon Historical Financial Ratios

BU Stock

CAD 0.12 0.01 9.09%

Burcon NutraScience is presently reporting on over 95 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 6.49 or Days Sales Outstanding of 253 will help investors to properly organize and evaluate Burcon NutraScience financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burcon NutraScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Burcon Financial Ratios Analysis

Burcon NutraScienceFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Burcon NutraScience investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Burcon financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Burcon NutraScience history.

Burcon NutraScience Financial Ratios Chart

At this time, Burcon NutraScience's Average Inventory is very stable compared to the past year. As of the 2nd of December 2024, Research And Ddevelopement To Revenue is likely to grow to 29.29, while Price To Sales Ratio is likely to drop 181.42.

Price To Sales Ratio Average Payables Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Burcon NutraScience stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Burcon NutraScience sales, a figure that is much harder to manipulate than other Burcon NutraScience multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Burcon NutraScience's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Burcon NutraScience current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burcon NutraScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2021	2023	2024 (projected)
Graham Number	0.74	0.24	0.23
Receivables Turnover	0.86	1.37	1.44

Graham Number Receivables Turnover

Burcon NutraScience fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.07	-0.11	-0.15	0.26	0.58	-0.68	-0.11	-0.07	1.0	0.69	0.18	0.04	0.47	-0.21	-0.46	-0.17	1.0	-0.08	-0.99	0.06	0.01	-1.0	-0.88	-0.09	0.17
Ptb Ratio	-0.07		-0.28	-0.02	0.63	-0.31	-0.19	-0.26	1.0	-0.07	-0.28	0.05	0.07	-0.1	-0.51	0.6	-0.38	-0.07	-0.05	0.02	0.1	0.22	0.02	-0.21	-0.03	-0.16
Days Sales Outstanding	-0.11	-0.28		0.32	-0.05	0.1	0.19	0.81	-0.28	-0.11	-0.02	0.02	0.03	0.12	0.19	-0.06	0.2	-0.11	0.59	0.12	0.2	-0.39	0.12	0.08	-0.09	0.23
Book Value Per Share	-0.15	-0.02	0.32		0.57	0.32	0.56	0.71	-0.02	-0.15	0.11	0.68	-0.49	0.37	0.47	-0.15	0.73	-0.15	0.81	0.05	-0.21	-0.79	0.1	0.27	0.56	0.19
Free Cash Flow Yield	0.26	0.63	-0.05	0.57		0.28	-0.07	0.21	0.63	0.26	0.22	0.53	-0.15	0.46	-0.16	0.16	0.1	0.26	0.45	-0.34	-0.1	-0.3	-0.32	-0.33	0.24	0.22
Operating Cash Flow Per Share	0.58	-0.31	0.1	0.32	0.28		-0.15	0.43	-0.31	0.58	0.97	0.59	-0.12	0.62	0.57	-0.87	0.56	0.58	0.14	-0.61	0.01	-0.54	-0.59	-0.2	0.25	0.06
Average Payables	-0.68	-0.19	0.19	0.56	-0.07	-0.15		0.42	-0.19	-0.68	-0.35	0.02	-0.57	-0.13	0.54	0.06	0.64	-0.68	0.26	0.63	-0.37	-0.51	0.67	0.75	0.46	0.11
Capex To Depreciation	-0.11	-0.26	0.81	0.71	0.21	0.43	0.42		-0.26	-0.11	0.23	0.4	-0.24	0.38	0.54	-0.31	0.69	-0.11	0.74	0.06	0.17	-0.83	0.09	0.26	0.39	0.22
Pb Ratio	-0.07	1.0	-0.28	-0.02	0.63	-0.31	-0.19	-0.26		-0.07	-0.28	0.05	0.07	-0.1	-0.51	0.6	-0.38	-0.07	-0.05	0.02	0.1	0.22	0.02	-0.21	-0.03	-0.16
Ev To Sales	1.0	-0.07	-0.11	-0.15	0.26	0.58	-0.68	-0.11	-0.07		0.69	0.18	0.04	0.47	-0.21	-0.46	-0.17	1.0	-0.08	-0.99	0.06	0.01	-1.0	-0.88	-0.09	0.17
Free Cash Flow Per Share	0.69	-0.28	-0.02	0.11	0.22	0.97	-0.35	0.23	-0.28	0.69		0.5	0.02	0.56	0.44	-0.85	0.35	0.69	-0.02	-0.7	0.03	-0.32	-0.68	-0.33	0.07	0.01
Roic	0.18	0.05	0.02	0.68	0.53	0.59	0.02	0.4	0.05	0.18	0.5		-0.19	0.35	0.51	-0.44	0.53	0.18	0.53	-0.23	-0.13	-0.49	-0.21	0.07	0.26	-0.29
Inventory Turnover	0.04	0.07	0.03	-0.49	-0.15	-0.12	-0.57	-0.24	0.07	0.04	0.02	-0.19		0.24	-0.36	0.13	-0.49	0.04	-0.15	0.02	0.4	0.48	-0.02	-0.16	-0.37	0.19
Net Income Per Share	0.47	-0.1	0.12	0.37	0.46	0.62	-0.13	0.38	-0.1	0.47	0.56	0.35	0.24		0.09	-0.41	0.39	0.47	0.34	-0.52	0.09	-0.53	-0.49	-0.32	0.49	0.66
Days Of Inventory On Hand	-0.21	-0.51	0.19	0.47	-0.16	0.57	0.54	0.54	-0.51	-0.21	0.44	0.51	-0.36	0.09		-0.72	0.84	-0.21	0.15	0.19	-0.23	-0.59	0.22	0.62	0.29	-0.25
Payables Turnover	-0.46	0.6	-0.06	-0.15	0.16	-0.87	0.06	-0.31	0.6	-0.46	-0.85	-0.44	0.13	-0.41	-0.72		-0.59	-0.46	0.07	0.46	0.12	0.43	0.44	0.0	-0.16	0.07
Average Inventory	-0.17	-0.38	0.2	0.73	0.1	0.56	0.64	0.69	-0.38	-0.17	0.35	0.53	-0.49	0.39	0.84	-0.59		-0.17	0.4	0.09	-0.13	-0.9	0.15	0.52	0.72	0.05
Capex To Revenue	1.0	-0.07	-0.11	-0.15	0.26	0.58	-0.68	-0.11	-0.07	1.0	0.69	0.18	0.04	0.47	-0.21	-0.46	-0.17		-0.08	-0.99	0.06	0.01	-1.0	-0.88	-0.09	0.17
Cash Per Share	-0.08	-0.05	0.59	0.81	0.45	0.14	0.26	0.74	-0.05	-0.08	-0.02	0.53	-0.15	0.34	0.15	0.07	0.4	-0.08		0.02	0.14	-0.61	0.05	0.05	0.35	0.25
Pocfratio	-0.99	0.02	0.12	0.05	-0.34	-0.61	0.63	0.06	0.02	-0.99	-0.7	-0.23	0.02	-0.52	0.19	0.46	0.09	-0.99	0.02		-0.09	0.09	1.0	0.87	-0.03	-0.2
Interest Coverage	0.06	0.1	0.2	-0.21	-0.1	0.01	-0.37	0.17	0.1	0.06	0.03	-0.13	0.4	0.09	-0.23	0.12	-0.13	0.06	0.14	-0.09		-0.1	-0.07	-0.16	0.21	-0.04
Capex To Operating Cash Flow	0.01	0.22	-0.39	-0.79	-0.3	-0.54	-0.51	-0.83	0.22	0.01	-0.32	-0.49	0.48	-0.53	-0.59	0.43	-0.9	0.01	-0.61	0.09	-0.1		0.03	-0.23	-0.8	-0.23
Pfcf Ratio	-1.0	0.02	0.12	0.1	-0.32	-0.59	0.67	0.09	0.02	-1.0	-0.68	-0.21	-0.02	-0.49	0.22	0.44	0.15	-1.0	0.05	1.0	-0.07	0.03		0.89	0.04	-0.19
Days Payables Outstanding	-0.88	-0.21	0.08	0.27	-0.33	-0.2	0.75	0.26	-0.21	-0.88	-0.33	0.07	-0.16	-0.32	0.62	0.0	0.52	-0.88	0.05	0.87	-0.16	-0.23	0.89		0.21	-0.26
Income Quality	-0.09	-0.03	-0.09	0.56	0.24	0.25	0.46	0.39	-0.03	-0.09	0.07	0.26	-0.37	0.49	0.29	-0.16	0.72	-0.09	0.35	-0.03	0.21	-0.8	0.04	0.21		0.26
Roe	0.17	-0.16	0.23	0.19	0.22	0.06	0.11	0.22	-0.16	0.17	0.01	-0.29	0.19	0.66	-0.25	0.07	0.05	0.17	0.25	-0.2	-0.04	-0.23	-0.19	-0.26	0.26

Click cells to compare fundamentals

Burcon NutraScience Account Relationship Matchups

Burcon NutraScience fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	2.3K	1.9K	753.6	80.67	190.96	181.42
Ptb Ratio	3.16	13.28	4.57	7.1	6.83	6.49
Days Sales Outstanding	3.9K	477.99	426.46	333.11	266.5	253.18
Book Value Per Share	0.29	0.35	0.26	0.0381	0.0425	0.0403
Free Cash Flow Yield	(0.0593)	(0.0123)	(0.0556)	(0.22)	(0.17)	(0.16)
Operating Cash Flow Per Share	(0.0347)	(0.0295)	(0.0545)	(0.0553)	(0.0476)	(0.05)
Stock Based Compensation To Revenue	16.54	6.37	8.37	3.45	4.4	4.18
Capex To Depreciation	42.06	23.31	4.85	0.54	0.18	0.17
Pb Ratio	3.16	13.28	4.57	7.1	6.83	6.49
Ev To Sales	2.1K	1.8K	713.2	90.88	204.35	194.14
Free Cash Flow Per Share	(0.0546)	(0.0574)	(0.0661)	(0.0586)	(0.0486)	(0.0511)
Roic	(0.13)	0.14	(0.26)	(0.82)	(0.61)	(0.64)
Net Income Per Share	(0.0587)	(0.006001)	(0.0945)	(0.23)	(0.0613)	(0.0644)
Payables Turnover	2.16	1.92	0.79	0.55	0.5	0.47
Sales General And Administrative To Revenue	94.54	16.89	24.48	10.26	19.66	18.68
Average Inventory	66.1K	132.3K	66.2K	34.2K	30.7K	34.1K
Research And Ddevelopement To Revenue	23.19	1.6	10.76	11.34	21.87	29.29
Capex To Revenue	50.37	11.11	7.4	0.99	0.69	0.66
Cash Per Share	0.19	0.14	0.0645	0.0134	0.0346	0.0328
Pocfratio	(26.52)	(158.77)	(21.85)	(4.88)	(6.09)	(6.4)
Interest Coverage	(6.32)	(5.96)	(102.0)	(16.14)	(13.72)	(14.41)
Capex To Operating Cash Flow	(0.57)	(0.95)	(0.21)	(0.0598)	(0.022)	(0.0231)
Pfcf Ratio	(16.86)	(81.54)	(17.99)	(4.6)	(5.96)	(6.26)
Days Payables Outstanding	168.72	189.76	460.38	658.51	592.66	622.29
Income Quality	0.59	4.91	0.58	0.24	0.78	0.69
Roe	(0.2)	(0.017)	(0.36)	(6.13)	(1.44)	(1.52)
Ev To Operating Cash Flow	(23.49)	(154.17)	(20.68)	(5.5)	(6.52)	(6.85)
Pe Ratio	(15.67)	(779.81)	(12.6)	(1.16)	(4.73)	(4.96)
Return On Tangible Assets	(3.95)	(0.16)	(0.0193)	(0.47)	(8.9)	(0.67)
Ev To Free Cash Flow	(14.94)	(79.18)	(17.03)	(5.19)	(6.38)	(6.7)
Earnings Yield	(0.0638)	(0.001282)	(0.0794)	(0.86)	(0.21)	(0.22)
Intangibles To Total Assets	0.0898	0.15	0.25	0.71	0.0972	0.0923
Net Debt To E B I T D A	2.25	(4.86)	0.7	(0.2)	(0.37)	(0.35)
Current Ratio	9.91	10.09	7.3	2.98	3.83	3.64
Tangible Book Value Per Share	0.26	0.3	0.19	(0.0268)	0.0321	0.0305
Receivables Turnover	0.0937	0.76	0.86	1.1	1.37	1.44
Graham Number	0.33	0.62	0.22	0.74	0.24	0.23
Shareholders Equity Per Share	0.29	0.35	0.26	0.0381	0.0425	0.0403

Other Information on Investing in Burcon Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity	Operating Cycle
Cash Conversion Cycle

Burcon Historical Financial Ratios

About Burcon Financial Ratios Analysis

Burcon NutraScience Financial Ratios Chart

Price To Sales Ratio

Average Payables

Ev To Sales

Burcon NutraScience fundamentals Correlations

Burcon NutraScience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Burcon NutraScience fundamentals Accounts

Other Information on Investing in Burcon Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Capex To Revenue	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Capex To Revenue	+ 1.0	Ev To Sales
Pfcf Ratio	+ 1.0	Pocfratio
Free Cash Flow Per Share	+ 0.97	Operating Cash Flow Per Share

Pfcf Ratio	- 1.0	Capex To Revenue
Pfcf Ratio	- 1.0	Ev To Sales
Pfcf Ratio	- 1.0	Price To Sales Ratio
Pocfratio	- 0.99	Capex To Revenue
Pocfratio	- 0.99	Ev To Sales
Pocfratio	- 0.99	Price To Sales Ratio